We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+3.28%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$3.77B
AUM Growth
-$97.1M
Cap. Flow
-$77.9M
Cap. Flow %
-2.07%
Top 10 Hldgs %
5.16%
Holding
1,474
New
108
Increased
302
Reduced
626
Closed
95

Sector Composition

Rank Sector Weight
1 Financials 25.33%
2 Consumer Discretionary 12.53%
3 Industrials 11.93%
4 Technology 10.13%
5 Energy 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSIT icon
1201
GSI Technology
GSIT
$258M
$120K ﹤0.01%
69,717
+11,000
+19% +$19.4K
DYN icon
1202
Dyne Therapeutics
DYN
$4.9B
$120K ﹤0.01%
10,400
ITI
1203
DELISTED
Iteris, Inc.
ITI
$120K ﹤0.01%
+25,500
New +$107K
OCC icon
1204
Optical Cable Corp
OCC
$143M
$119K ﹤0.01%
27,600
CATX icon
1205
Perspective Therapeutics
CATX
$342M
$117K ﹤0.01%
18,400
DXYN
1206
DELISTED
Dixie Group Inc
DXYN
$117K ﹤0.01%
153,700
-78,500
-34% -$68.2K
SGTX
1207
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$116K ﹤0.01%
9,615
XGN icon
1208
Exagen
XGN
$166M
$115K ﹤0.01%
47,300
BCEL
1209
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$114K ﹤0.01%
100,000
HCWB icon
1210
HCW Biologics
HCWB
$5.45M
$114K ﹤0.01%
344
+41
+14% +$17.8K
CLNN icon
1211
Clene
CLNN
$67.5M
$114K ﹤0.01%
5,039
PVLA
1212
Palvella Therapeutics
PVLA
$2.27B
$114K ﹤0.01%
1,456
RAIN
1213
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$114K ﹤0.01%
+13,000
New +$120K
SER icon
1214
Serina Therapeutics
SER
$36M
$113K ﹤0.01%
4,827
SPPI
1215
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$113K ﹤0.01%
+150,000
New +$109K
SNTI icon
1216
Senti Biosciences Holdings
SNTI
$11M
$112K ﹤0.01%
9,500
SIF icon
1217
SIFCO Industries
SIF
$176M
$112K ﹤0.01%
37,234
-1,790
-5% -$5.31K
KLR
1218
DELISTED
Kaleyra, Inc.
KLR
$111K ﹤0.01%
67,400
CTHR
1219
DELISTED
Charles & Colvard Ltd
CTHR
$111K ﹤0.01%
11,889
CRGE
1220
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$111K ﹤0.01%
+100,500
New +$127K
NNVC icon
1221
NanoViricides
NNVC
$36.2M
$110K ﹤0.01%
94,039
CLPR
1222
Clipper Realty
CLPR
$46.2M
$108K ﹤0.01%
+18,863
New +$125K
NAUT icon
1223
Nautilus Biotechnolgy
NAUT
$115M
$107K ﹤0.01%
+38,800
New +$81.4K
HTBK
1224
DELISTED
Heritage Commerce
HTBK
$107K ﹤0.01%
12,900
-65,000
-83% -$744K
ELEV
1225
DELISTED
Elevation Oncology
ELEV
$107K ﹤0.01%
56,500
-78,000
-58% -$101K

Similar funds

Bridgeway Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Bridgeway Capital Management held 1,474 positions worth $3.77B, down 2.5% from $3.86B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

Bridgeway Capital Management's Q1 2023 filing shows 108 new, 302 increased, 626 reduced and 95 closed positions. Its largest new stake was Coterra Energy: 364,600 shares worth $8.95M. The largest sale was Meta Platforms (Facebook), an estimated $23M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q1 2023 buy was Coterra Energy: 364,600 shares worth $8.95M.
  • Bridgeway Capital Management added most to Netflix in Q1 2023, an estimated $13M increase.
  • Bridgeway Capital Management's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $23M.
  • Bridgeway Capital Management fully exited Atlas Air Worldwide Holdings, Inc. in Q1 2023, selling an estimated $17.7M.
  • Bridgeway Capital Management's ten largest holdings make up 5.2% of its $3.77B portfolio in Q1 2023.
  • Bridgeway Capital Management opened 108 new positions and closed 95 in Q1 2023.
  • Bridgeway Capital Management's portfolio value fell 2.5% quarter-over-quarter to $3.77B.

Based on Bridgeway Capital Management's 13F filing for Q1 2023, filed 15 May 2023.